title: Revealing the incidentalome when targeting the tumor genome.
authors: Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
authors: Yvonne
authors: Y
authors: Bombard
authors: Mark
authors: M
authors: Robson
authors: Kenneth
authors: K
authors: Offit
mesh_terms: D004273:DNA, Neoplasm / Q000235:genetics / Q000302:isolation & purification; D003657:Decision Making; D030881:Disclosure; D005817:Genetic Counseling; D005820:Genetic Testing / Q000941:ethics; D018095:Germ-Line Mutation; D006801:Humans; D033162:Incidental Findings; D009369:Neoplasms / Q000175:diagnosis / Q000235:genetics / Q000628:therapy; D057285:Precision Medicine; D011446:Prospective Studies; D012189:Retrospective Studies; D017422:Sequence Analysis, DNA
chemical_list: D004273:DNA, Neoplasm
references: Genet Med. 2013 Jul;15(7):565-74
references: 23788249
references: JAMA. 2011 Apr 20;305(15):1596-7
references: 21505140
references: JAMA. 2013 Jul 24;310(4):369-70
references: 23917282
references: JAMA. 2013 Jul 24;310(4):367-8
references: 23917281
references: Genet Med. 2013 Sep;15(9):721-8
references: 23558254
references: J Natl Compr Canc Netw. 2013 Nov;11(11):1343-53
references: 24225968
references: Eur J Hum Genet. 2013 Nov;21(11):1197-201
references: 23340511
references: JAMA. 2004 Sep 22;292(12):1469-73
references: 15383518
references: Am J Bioeth. 2012;12(10):12-4
references: 22974020